Table 4. Univariate and multivariate analyses of progonostic factors for 3-year disease free survival in patients with TSCC.

	Univariate			Multivariate
	HR	95% CI	p-value	HR	95% CI	p-value
HPV+TSCC
CD8+	0.27	(0.09–0.88)	0.029	0.28	(0.084–0.91)	0.034
stage	0.85	(0.11–6.48)	0.88			1
age	5.5	(1.55–19.6)	0.008	5.58	(1.5–20.4)	0.009
sex	0.83	(0.27–2.62)	0.75	0.68	(0.21–2.22)	0.52
HPV-TSCC
CD8+/Foxp3+	0.27	(0.073–0.99)	0.048	0.21	(0.057–0.81)	0.023
stage	6.91	(0.89–53.6)	0.064	8.9	(1.12–70.6)	0.039
age	0.74	(0.23–2.4)	0.62	0.64	(0.18–2.31)	0.50
sex	1.08	(0.56–2.05)	0.83	0.92	(0.46–1.87)	0.83

Abbreviations: HR, hazard ratio; CI, confidence interval.